| Liraglutide and cardiovascular outcomes in type 2 diabetes SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ... New England Journal of Medicine 375 (4), 311-322, 2016 | 7215 | 2016 |
| Physiology of local renin-angiotensin systems M Paul, A Poyan Mehr, R Kreutz Physiological reviews 86 (3), 747-803, 2006 | 2391 | 2006 |
| Liraglutide and renal outcomes in type 2 diabetes JFE Mann, DD Ørsted, K Brown-Frandsen, SP Marso, NR Poulter, ... New England Journal of Medicine 377 (9), 839-848, 2017 | 1228 | 2017 |
| Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment KJ Jang, AP Mehr, GA Hamilton, LA McPartlin, S Chung, KY Suh, ... Integrative Biology 5 (9), 1119-1129, 2013 | 894 | 2013 |
| De novo NAD+ biosynthetic impairment in acute kidney injury in humans A Poyan Mehr, MT Tran, KM Ralto, DE Leaf, V Washco, J Messmer, ... Nature medicine 24 (9), 1351-1359, 2018 | 310 | 2018 |
| Early onset albuminuria in Dahl rats is a polygenetic trait that is independent from salt loading A Poyan Mehr, AK Siegel, P Kossmehl, A Schulz, R Plehm, JA de Bruijn, ... Physiological genomics 14 (3), 209-216, 2003 | 48 | 2003 |
| The CSL112-2001 trial: safety and tolerability of multiple doses of CSL112 (apolipoprotein AI [human]), an intravenous formulation of plasma-derived apolipoprotein AI, among … CM Gibson, M Kerneis, MK Yee, Y Daaboul, S Korjian, AP Mehr, P Tricoci, ... American heart journal 208, 81-90, 2019 | 41 | 2019 |
| Genetic loci contribute to the progression of vascular and cardiac hypertrophy in salt-sensitive spontaneous hypertension AK Siegel, M Planert, S Rademacher, AP Mehr, P Kossmehl, M Wehland, ... Arteriosclerosis, thrombosis, and vascular biology 23 (7), 1211-1217, 2003 | 34 | 2003 |
| Niacinamide may be associated with improved outcomes in COVID-19-related acute kidney injury: an observational study NH Raines, S Ganatra, P Nissaisorakarn, A Pandit, A Morales, A Asnani, ... Kidney360 2 (1), 33-41, 2021 | 33 | 2021 |
| Mercury and zinc differentially inhibit shark and human CFTR orthologues: involvement of shark cysteine 102 GJ Weber, AP Mehr, JC Sirota, SG Aller, SE Decker, DC Dawson, ... American Journal of Physiology-Cell Physiology 290 (3), C793-C801, 2006 | 23 | 2006 |
| Functional and molecular identification of a TASK-1 potassium channel regulating chloride secretion through CFTR channels in the shark rectal gland: implications for cystic … CJ Telles, SE Decker, WW Motley, AW Peters, AP Mehr, RA Frizzell, ... American Journal of Physiology-Cell Physiology 311 (6), C884-C894, 2016 | 14 | 2016 |
| The glomerular disease study and trial consortium: a grassroots initiative to foster collaboration and innovation AP Mehr, M Sadeghi-Najafabadi, K Chau, J Messmer, R Pai, N Roy, ... Kidney International Reports 4 (1), 20-29, 2019 | 13 | 2019 |
| The use of virtual physician mentoring to enhance home dialysis knowledge and uptake J Ashley, G Abra, B Schiller, PN Bennett, AP Mehr, JM Bargman, CT Chan Nephrology 26 (7), 569-577, 2021 | 7 | 2021 |
| PPARγ-coactivator-1α, nicotinamide adenine dinucleotide and renal stress resistance A Poyan Mehr, SM Parikh Nephron 137 (4), 253-255, 2017 | 7 | 2017 |
| Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb) 5: 1119–1129 KJ Jang, AP Mehr, GA Hamilton, LA McPartlin, S Chung, KY Suh, ... | 7 | 2013 |
| Innovating and invigorating the clinical trial infrastructure for glomerular diseases L Barisoni, J Barratt, K Campbell, L Eva, BS Gillespie, D Gipson, T Huber, ... Kidney international 99 (3), 519-523, 2021 | 4 | 2021 |
| Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr Biol (Camb). 2013; 5 (9): 1119–29 KJ Jang, AP Mehr, GA Hamilton, LA McPartlin, S Chung, KY Suh, ... This study utilizes a multilayer microfluidic system—comprised of two …, 0 | 4 | |
| The implementation of a virtual home dialysis mentoring program for nephrologists G Abra, AP Mehr, CT Chan, B Schiller Kidney360 3 (4), 734-736, 2022 | 3 | 2022 |
| Prescribing patterns for sodium-glucose cotransporter 2 inhibitors: a survey of nephrologists T Singh, T Li, D Mandelbrot, BC Astor, AP Mehr Kidney International Reports 8 (8), 1669-1671, 2023 | 2 | 2023 |
| Glomerular disease education experience across nephrology fellowship programs: an international survey H Seethapathy, S Norouzi, KJ Robson, L Gharibvand, AP Mehr Glomerular Diseases 2 (2), 89-94, 2022 | 2 | 2022 |
Reinhold KreutzProfessor of Clinical Pharmacology, Charite University Medicine Berlin在 charite.de 的电子邮件经过验证
